AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn’s Disease TranscriptOctober 2, 2026
Fed’s Kashkari says inflation is ‘still too high’ even after softer-than-expected PCE dataOctober 2, 2026
Would you renew this supplier? Burnham and the Hillsborough Law SMEs July 12, 2026 Each quarter, in a gathering room with unhealthy biscuits, my staff and I sit down and rating our suppliers. It…
